Cumulative survival in early-onset unilateral and bilateral breast cancer: An analysis of 1907 Taiwanese women

British Journal of Cancer

Volumn 100, Issue 4, 2009, Pages 563-570

  Kuo, W H ^a,b   Yen, A M F ^b   Lee, P H ^a,b   Chen, K M ^a   Wang, J ^a   Chang, K J ^a,b   Chen, T H H ^b   Tsau, H S ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Bilateral breast cancer; Early onset breast cancer; Metachronous breast cancer; Survival; Synchronous breast cancer

Indexed keywords

ADULT; ARTICLE; BILATERAL CANCER; BREAST CANCER; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TAIWAN;

ADULT; AGE OF ONSET; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TAIWAN;

EID: 60349091874     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604898     Document Type: Article

References (31)

1. Aebi S, Gelber S, Castiglione-Gertsch M, Gellber RD, Collins J, Thurlimann B, Rudenstam CM, Lindtner J, Crivellari D, Cortes-Funes H, Simoncini E, Werner ID, Coates AS, Goldhirsch A for the International Breast Cancer Study Group (IBCSG) (2000) Is chemotherapy alone adequate for young women with oestrogen receptor-positive breast cancer? Lancet 355: 1869-1874
2. Ahn SH, Korean Breast Cancer Society (2004) Clinical characteristics of breast cancers in Korea in 2000. Arch Surg 139: 27-30
3. Ahn SH, Son BH, Kim SW, Kim SI, Jeong J, Ko SS, Han W (2007) Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: Nationwide survival data in Korea - A report from the Korean Breast Cancer Society. J Clin Oncol 25: 2360-2368
4. Alexander AI, Mercer RJ, Muir IM, Mason B, Holdaway I (1989) Predicting survival in bilateral breast carcinoma. Aust NZ J Surg 59: 35-37
5. Anders CK, Hsu DS, Broadwater G, Ncharya CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG, Nevins JR, Potti A, Blackwell KL (2008) Young Age at Diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26: 3324-3330
6. Brenner H, Engelsmann B, Stegmaier C, Ziegler H (1993) Clinical epidemiology of bilateral breast cancer. Cancer 72: 3629-3635
7. Chia KS, Reilly M, Tan CS, Lee J, Pawitan Y, Adami HO, Hall P, Mow B (2005) Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: a comparative population-based study in Singapore and Sweden. Int J Cancer 113: 302-306
8. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2005a) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365: 1687-1717
9. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2005b) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366: 2087-2106
10. Fisher ER, Fisher B, Sass R, Wickerham L (1984) Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). XI. Bilateral breast cancer. Cancer 54: 3002-3011
11. FitzGerald MG, MacDonald DJ, Krainer M, Hoover I, O'Neil E, Unsal H, Silva-Arrieto S, Finkelstein DM, Beer-Romero P, Englert C, Sgroi DC, Smith BL, Younger JW, Garber JE, Duda RB, Mayzel KA, Isselbacher KJ, Friend SH, Haber DA (1996) Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. New Engl J Med 334: 143-149
12. Greenland S, Finkle WD (1995) A critical look at methods for handling missing covariates in epidemiologic regression analyses. Am J Epidemiol 142: 1255-1264
13. Hartman M, Czene K, Reilly M, Adolfsson J, Bergh J, Adami HO, Dickman PW, Hall P (2007) Incidence and prognosis of synchronous and metachronous bilateral breast cancer. J Clin Oncol 25: 4210-4216
14. IARC (2002) website: http://www-dep.iarc.fr/globocan/database.htm
15. Kollias J, Ellis IO, Elston CW, Blamey RW (2001) Prognostic significance of synchronous and metachronous bilateral breast cancer. World J Surg 25: 1117-1124
16. Kuo WH, Yen AMF, Lee PH, Hou MF, Chen SC, Chen KM, Chen TH, Chang KJ (2006) Incidence and risk factors associated with bilateral breast cancer in area with early age diagnosis but low incidence of primary breast cancer: analysis of 10-year longitudinal cohort in Taiwan. Breast Ca Research Treat 99: 221-228
17. Leung AW, Mak J, Cheung PS, Epstein RJ (2008) Evidence for a programming effect of early menarche on the rise of breast cancer incidence in Hong Kong. Cancer Detect Prev 32: 156-161
18. Matsuno RK, Anderson WF, Yamamoto S, Tsukuma H, Pfeiffer RM, Kobayashi K, Devesa SS, Levine PH (2007) Early- and late-onset breast cancer types among women in the United States and Japan. Cancer Epidemiol Biomarkers Prev 16: 1437-1442
19. Minami Y, Tsubono Y, Nishino Y, Ohuchi N, Shibuya D, Hisamichi S (2004) The increase of female breast cancer incidence in Japan: emergence of birth cohort effect. Int J Cancer 108: 901-906
20. Moller P, Evans DG, Reis MM, Gregory H, Anderson E, Maehle L, Lalloo F, Howell A, Apold J, Clark N, Lucassen A, Steel CM (2007) Surveillance for familial breast cancer: differences in outcome according to BRCA mutation status. Int J Cancer 121: 1017-1020
21. Mose S, Adamietz IA, Thilmann C, Saran F, Bernhard M, Pahnke R, Böttcher HD (1997) Bilateral breast carcinoma versus unilateral disease. Review of 498 patients. Am J Clin Oncol 20: 541-545
22. Newman LA, Sahin AA, Cunningham JE, Bondy ML, Mirza NQ, Vlastos GS, Whitman GJ, Brown H, Buchholz TA, Lee MH, Singletary SE (2001) A case-control study of unilateral and bilateral breast carcinoma patients. Cancer 91: 1845-1853
23. Nomura Y, Tsutsui S, Murakami S, Takenaka Y (1999) Prognostic impact of second cancer on the survival of early breast cancer patients. Int J Oncol 14: 1103-1109
24. Rennert G, Bisland-Naggan S, Barnett-Griness O, Bar-Joseph N, Zhang S, Rennert HS, Narod SA (2007) Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutation. New Engl J Med 357: 115-123
25. Rubinstein WS (2004) Hereditary breast cancer in Jews. Familial Cancer 3: 249-257
26. Seow A, Duffy SW, McGee MA, Lee J, Lee HP (1996) Breast cancer in Singapore: trends in incidence 1978-1992. Int J Epidemiol 25: 40-45
27. Shen YC, Chang CJ, Hsu C, Cheng CC, Chiu CF (2005) Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: implications from age-period-cohort analysis. Cancer Epidemiol Biomark Prev 14: 1986-1990
28. Sim X, Ali RA, Wedren S, Goh DL, Tan CS, Reilly M, Hall P, Chia KS (2006) Ethnic differences in the time trend of female breast cancer incidence: Singapore, 1968-2002. BMC Cancer 6(1): 261
29. Tutt A, Ashworth A (2008) Can genetic testing guide treatment in breast cancer? Eur J Cancer 44: 2774-2780
30. Yang L, Parkin DM, Ferlay J, Li L, Chen Y (2005) Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 14: 243-250
31. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF, Hyer MB (1993) Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 17: 1819-1827